DANTE GENOME HOUSE LTD
Company number 13073074 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£2,065,617
Balance sheet as at 2025-12-31
What it does
The company develops solutions for genomics analysis in research use (RUO) and clinical use, in the life sciences and genomics sector.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-12-09
- Employees
- 1 (2025 accounts · was 2 in 2024)
- Registered office
- 86-90 Paul Street, 3rd Floor, London, England, EC2A 4NE
- Postcode
- EC2A 4NE
- Capital
- 1,000 GBP
- Accounts category
- Unaudited Abridged
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-12-08
- Next due by
- 2026-12-22
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 1 current · 3 resigned
Group structure 1 subsidiary
-
DANTE FUTURE TECHNOLOGY LTD Dissolved
From persons-with-significant-control filings on the public register.
Among its peers
Top 10%
by shareholders' funds, of 138 similar companies in EC
Trading since 2020.
No.12 of the largest research and experimental development on biotechnology companies in London →
Competitors London
This company ranks 12 among research and experimental development on biotechnology in London.
The class of 2020
41%
of the 595 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.
A fact about the year, not a forecast for this company.